STEPHANIE GARZA: Open Payments
NPI 1265080477 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$684 in 52 payments from 13 companies in 2025. Trend: 2023 $446 · 2024 $543 · 2025 $684
Food & beverage: $684
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $178 |
| PFIZER INC. | 14 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Abbott Laboratories | 3 | $54 |
| Novo Nordisk Inc | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Almatica Pharma LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Phadia US Inc. | 1 | $18 |
Products named: NURTEC ODT, CAPLYTA, QULIPTA, VRAYLAR, TRINTELLIX, FREESTYLE LIBRE 3, PAXLOVID, UBRELVY.
Industry payments across AZ — which companies pay providers there.
